Want to join the conversation?
Medical device maker $EW reported a rise in 1Q16 earnings driven by continued strong adoption in the U.S. for its transcatheter heart valve therapy. Net income rose to $143 or $0.66 per share from $123.4 or $0.56 per share last year. Net sales grew to $697.3MM from $590.3MM. Adjusted EPS increased by 24.6% to $0.71.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?